Van Roy, M <br/><br/>
The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.  [electronic resource] 

 -  Cancer gene therapy  Apr 2007 
 - 372-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0929-1903 
<br/><br/><label>Standard No.: </label>10.1038/sj.cgt.7701020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Combined Modality Therapy<br/>Genetic Therapy<br/>Genetic Vectors<br/>Interferon-gamma--therapeutic use<br/>Melanoma, Experimental--drug therapy<br/>Mice<br/>Skin Neoplasms--drug therapy<br/>Tissue Inhibitor of Metalloproteinase-1--genetics<br/>Tissue Inhibitor of Metalloproteinase-2--genetics<br/>Treatment Outcome<br/>Tumor Necrosis Factors--therapeutic use